ArticleBioengineered2022

CircPTK2 inhibits cell cisplatin (CDDP) resistance by targeting miR-942/TRIM16 axis in non-small cell lung cancer (NSCLC).

Yongfu Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.